Search research articles
Contact Us
Filters
Showing results (211-220 of 257) with videos related to
Page
of 26
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
August 1, 2025
Robotic-assisted bronchoscopy for histopathologic subtyping of primary lung adenocarcinoma
Or Kalchiem-Dekel, Rastko Rakočević, Nicolas Toumbacaris, et al.
Gynecologic Oncology
|
February 14, 2015
Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons
Jamie N Bakkum-Gamez, Nicolas Wentzensen, Matthew J Maurer, et al.
Gastro Hep Advances
|
August 12, 2024
Discovery and Validation of Methylated DNA Markers From Pancreatic Neuroendocrine Tumors
Shounak Majumder, Thorvardur R Halfdanarson, Calise K Berger, et al.
Gynecologic Oncology
|
June 6, 2012
A phase 2 trial of flavopiridol (Alvocidib) and cisplatin in platin-resistant ovarian and primary peritoneal carcinoma: MC0261
Keith C Bible, Prema P Peethambaram, Ann L Oberg, et al.
Oncotarget
|
February 11, 2017
Combination epigenetic therapy in metastatic colorectal cancer (mCRC) with subcutaneous 5-azacitidine and entinostat: a phase 2 consortium/stand up 2 cancer study
Nilofer S Azad, Anthony El-Khoueiry, Jun Yin, et al.
Cancer & Metabolism
|
September 17, 2014
Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancer
Debarshi Roy, Susmita Mondal, Chen Wang, et al.
Cancer & Metabolism
|
June 16, 2015
Erratum to: Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancer
Debarshi Roy, Susmita Mondal, Chen Wang, et al.
Gynecologic Oncology
|
June 18, 2019
Genes associated with bowel metastases in ovarian cancer
Andrea Mariani, Chen Wang, Ann L Oberg, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
November 8, 2024
Early detection of pancreatic cancer: Study design and analytical considerations in biomarker discovery and early phase validation studies
Lynette M Smith, Douglas W Mahoney, William R Bamlet, et al.
Molecular Cancer
|
October 7, 2024
Proapoptotic activity of JNK-sensitive BH3-only proteins underpins ovarian cancer response to replication checkpoint inhibitors
Annapoorna Venkatachalam, Cristina Correia, Kevin L Peterson, et al.
Page
of 26
Search research articles
Search
Showing results (211-220 of 257) with videos related to
Sort By:
Page
of 26
Lung Cancer (Amsterdam, Netherlands)
|
August 1, 2025
Robotic-assisted bronchoscopy for histopathologic subtyping of primary lung adenocarcinoma
Or Kalchiem-Dekel, Rastko Rakočević, Nicolas Toumbacaris, et al.
Gynecologic Oncology
|
February 14, 2015
Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons
Jamie N Bakkum-Gamez, Nicolas Wentzensen, Matthew J Maurer, et al.
Gastro Hep Advances
|
August 12, 2024
Discovery and Validation of Methylated DNA Markers From Pancreatic Neuroendocrine Tumors
Shounak Majumder, Thorvardur R Halfdanarson, Calise K Berger, et al.
Gynecologic Oncology
|
June 6, 2012
A phase 2 trial of flavopiridol (Alvocidib) and cisplatin in platin-resistant ovarian and primary peritoneal carcinoma: MC0261
Keith C Bible, Prema P Peethambaram, Ann L Oberg, et al.
Oncotarget
|
February 11, 2017
Combination epigenetic therapy in metastatic colorectal cancer (mCRC) with subcutaneous 5-azacitidine and entinostat: a phase 2 consortium/stand up 2 cancer study
Nilofer S Azad, Anthony El-Khoueiry, Jun Yin, et al.
Cancer & Metabolism
|
September 17, 2014
Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancer
Debarshi Roy, Susmita Mondal, Chen Wang, et al.
Cancer & Metabolism
|
June 16, 2015
Erratum to: Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancer
Debarshi Roy, Susmita Mondal, Chen Wang, et al.
Gynecologic Oncology
|
June 18, 2019
Genes associated with bowel metastases in ovarian cancer
Andrea Mariani, Chen Wang, Ann L Oberg, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
November 8, 2024
Early detection of pancreatic cancer: Study design and analytical considerations in biomarker discovery and early phase validation studies
Lynette M Smith, Douglas W Mahoney, William R Bamlet, et al.
Molecular Cancer
|
October 7, 2024
Proapoptotic activity of JNK-sensitive BH3-only proteins underpins ovarian cancer response to replication checkpoint inhibitors
Annapoorna Venkatachalam, Cristina Correia, Kevin L Peterson, et al.
Page
of 26